Germany has approved higher pharmaceutical rebates, with AstraZeneca warning the measures could reduce investment, research and access to medicines.
pharmaceuticals
1Article
- Home
- pharmaceuticals
Recent Posts
- Why easyJet’s uncertain future becomes a test of UK aviation and capital markets
- Global Oil Markets at the Edge of Fracture
- OpenAI’s No. 2 Executive to Step Down Amidst Pre-IPO Turmoil and Shifting Market Dynamics
- Segro at a crossroads: Sleath’s steadfast stand against Prologis’s £12.6bn bid
- Burnham Urged to Consider Modernising Building Societies Act Amid Election Dispute
- Dukes and Dissent: Ground rents, lobbying, and the quiet calculus of a leasehold reform
- British eyes on a corporate reckoning: BAT and the North Korea chapter
- The British Exiles and the Price of Trust: A £150m Service Station Ponzi Scheme
- GPs Retreat From Full-Time Practice Amid Growing Disillusionment with the NHS
- Spain’s solar boom and the price of ambition
- Germany Approves Drug Rebate Increase as AstraZeneca Warns of Investment Impact
- FCA Review Warns AI Chatbots Are Blurring the Line Between Guidance and Regulated Advice
- Bank of England Proposes Easing Leverage Rules for Major UK Lenders
- Capita Warns Civil Service Pension Failures Could Cost Up to £40 Million
- UK Brings Microsoft, Google, Amazon and Oracle Under Direct Financial-Sector Oversight
- Arc Minerals Readies August Drilling at Botswana’s Virgo Copper Project
- AstraZeneca Slides After Wainua Misses Cardiovascular Goal in Late-Stage Trial
- Revolut Hires Former Chase UK Chief Kuba Fast to Accelerate European Banking Expansion
- Panther Metals Expands Wishbone Drilling After Multiple Sulphide Intersections
- BP CEO Signals Tighter Spending and Sharper Focus on Core Oil and Gas
- Watches of Switzerland Downgraded by Jefferies as Valuation Rerating Runs Its Course
- Rio Tinto May Require Enhanced Copper Pipeline to Address Post 2030 Growth Gap UBS Analysis Suggests
- Meta Platforms to Construct 9 Billion USD AI Data Centre in Alberta Canada
- Bitcoin bettors see a bounce but the big targets stay long odds
- Vodafone Shares Surge as French Billionaire Niel Acquires 4 Billion Pound Stake from Abu Dhabi Operator
- Grok 45 Delivers Opus Class Performance at Lower Cost But Questions Remain
- Rockfire Resources Receives High Grade Assay Results from Marengo Goldfield Partner
- Krakatoa Drilling Confirms Visual Antimony at Zopkhito as JORC Resource Push Builds
- Chariot Ltd Plans 25 for 1 Share Consolidation Amid Strategic Shift to Angola Operations
- Revolut poaches Chase UK boss Kuba Fast to help its Europe push
